BioStock: Key advancements for Alligator Bioscience in Q2

As indicated in the financial report released this morning, Q2 was an important quarter for biotech company Alligator Bioscience. It marked the beginning of Søren Bregenholt’s tenure as CEO for the company, and it also brought positive data for Alligator’s top projects: Mitazalimab and ATOR-1017.

Read the whole article at biostock.se:

https://www.biostock.se/2021/07/key-advancements-for-alligator-bioscience-in-q2/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/